Post-tuberculosis lung disease: is there a light at the end of tunnel?

Affiliations

¹ Department of Medicine, Therapeutics, and Dermatology, Kenyatta University, Nairobi, Kenya; Respiratory Society of Kenya, Nairobi, Kenya. Electronic address: chakaya.jm@gmail.com.
² Common Management Unit (TB, HIV/AIDS & Malaria), Ministry of National Health Services, Regulation and Coordination, Islamabad, Pakistan.
³ National Program for Tuberculosis Control and Chest Disease, Ministry of Health, Colombo, Sri Lanka.
⁴ International Union Against Tuberculosis and Lung Disease, Paris, France; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Jeremiah Chakaya et al. Lancet Infect Dis. 2024 Jul.

. 2024 Jul;24(7):677-679.

doi: 10.1016/S1473-3099(24)00136-1. Epub 2024 Mar 22.

¹ Department of Medicine, Therapeutics, and Dermatology, Kenyatta University, Nairobi, Kenya; Respiratory Society of Kenya, Nairobi, Kenya. Electronic address: chakaya.jm@gmail.com.
² Common Management Unit (TB, HIV/AIDS & Malaria), Ministry of National Health Services, Regulation and Coordination, Islamabad, Pakistan.
³ National Program for Tuberculosis Control and Chest Disease, Ministry of Health, Colombo, Sri Lanka.
⁴ International Union Against Tuberculosis and Lung Disease, Paris, France; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.

No abstract available

Conflict of interest statement

We declare no competing interests.